Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Mood and Cognition in Glioblastoma
NCT02443194Phase 3Terminated
- Start
- May 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of duloxetine in major depressive disorder (MDD). Started May 2015; status: terminated.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02443194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443194.